Iradimed Corporation (NASDAQ:IRMD – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 74,400 shares, a growth of 8.9% from the September 15th total of 68,300 shares. Based on an average daily trading volume, of 49,800 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.9% of the shares of the stock are sold short.
Analyst Upgrades and Downgrades
Separately, Roth Mkm lowered their price target on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, August 2nd.
Get Our Latest Stock Report on IRMD
Institutional Inflows and Outflows
Iradimed Stock Performance
Shares of IRMD stock opened at $51.55 on Thursday. The company has a market capitalization of $652.83 million, a PE ratio of 36.56 and a beta of 0.79. Iradimed has a 52-week low of $37.51 and a 52-week high of $51.86. The business’s fifty day moving average is $47.41 and its 200 day moving average is $44.79.
Iradimed (NASDAQ:IRMD – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The medical equipment provider reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.05. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. The firm had revenue of $17.93 million during the quarter, compared to the consensus estimate of $17.70 million. During the same quarter last year, the company posted $0.33 EPS. On average, sell-side analysts forecast that Iradimed will post 1.41 EPS for the current fiscal year.
Iradimed Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Tuesday, August 20th were issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend was Tuesday, August 20th. Iradimed’s dividend payout ratio is currently 42.55%.
About Iradimed
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.
Read More
- Five stocks we like better than Iradimed
- The How And Why of Investing in Oil Stocks
- Broadcom’s Targeted Upside Just Keeps Getting Better
- What is an Earnings Surprise?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.